ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.79
+0.07%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$1.24
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$1.77
- EPS estimate
- -$1.12
- Revenue actual
- $1.0M
- Revenue estimate
- $15.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -114.5%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $45
- PT range
- $32 – $55
- Analysts
- 5
4 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$1.12 | -$1.77 | Miss -58.04% | $1.0M |
| May 13, 2026 | -$1.37 | -$1.46 | Miss -6.57% | — |
| Mar 16, 2026 | -$1.00 | -$4.54 | Miss -353.36% | — |
| Nov 12, 2025 | -$0.87 | -$1.22 | Miss -40.23% | — |
| May 15, 2025 | -$1.11 | -$0.80 | Beat 27.93% | $10.0M |
| Mar 25, 2025 | -$0.92 | -$3.99 | Miss -333.70% | $5.0M |
| Jun 30, 2024 | — | -$0.99 | — | — |
| Mar 31, 2024 | — | -$0.73 | — | — |
| Dec 31, 2023 | — | -$0.64 | — | — |
| Sep 30, 2023 | — | $0.85 | — | $50.0M |
| Jun 30, 2023 | — | -$0.76 | — | — |
| Mar 31, 2023 | — | -$0.50 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 12, 2027